Skip to content

Chinese Cardiomyopathy Cardiac Magnetic Resonance Registration Study

Chinese Cardiomyopathy Cardiac Magnetic Resonance Registration Study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122493
Enrollment
Unknown
Registered
2026-04-14
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), arrhythmic cardiomyopathy (ACM), and other hereditary or unclassified cardiomyopathies

Interventions

Patients with cardiomyopathy:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Comply with the definitions of international/domestic guidelines related to cardiomyopathy, complete CMR examination, sign the informed consent form (prospective), and obtain ethical approval from the center

Exclusion criteria

Exclusion criteria: 1. Refusing to use their personal clinical data, imaging materials and biological samples; 2. Incomplete clinical data, making it impossible to complete at least 5-year follow-up; 3. The CMR image quality does not meet the research quality control requirements and cannot be re-examined; 4. There are absolute contraindications for CMR examination, including but not limited to: having electronic devices implanted in the body (such as pacemakers, implantable cardioverter defibrillators (ICDs), nerve stimulators, etc.), having metal foreign bodies in the body (such as metal foreign bodies in the eyeball, unremoved shrapids, etc.), and having claudephobia and being unable to cooperate to complete the CMR examination. 5. Those with severe coagulation dysfunction, bleeding tendency, or inability to cooperate in completing peripheral blood collection; 6. Those who the researcher believes are not suitable to participate in this study due to other health conditions, cognitive abilities or objective conditions, etc.

Design outcomes

Primary

MeasureTime frame
Clinical data (demographic information, chief complaint duration, medical history, laboratory parameters, etc.);Cardiac Magnetic Resonance (CMR) imaging data (cine, T1/T2 mapping, LGE, DICOM files, and structured reports);Safety outcomes (including claustrophobia, noise and positional discomfort, serious adverse events (SAEs));

Countries

China

Contacts

Public ContactChen Yucheng

West China Hospital of Sichuan University

chenyucheng2003@126.com+86 189 8060 2149

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026